CS logo
small CS logo
Norton Cancer Institute Research Program

Louisville, Kentucky, United States
Oncologist in Louisville, Kentucky
4950 Norton Healthcare Blvd Suite 300, Louisville, KY 40241

About Norton Cancer Institute Research Program


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Clovis Oncology, Inc.
1
MacroGenics
1
Total Rows: 2

Clinical Trials at Norton Cancer Institute Research Program


During the past decade, Norton Cancer Institute Research Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201500.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma
2011-04-01
2013-03-01
Completed
19
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
2015-07-01
2021-08-18
Completed
145

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsClovis Oncology, Inc.: 1Clovis Oncology, Inc.: 1MacroGenics: 1MacroGenics: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Norton Cancer Institute Research Program


According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute Research Program" are "Head and Neck Cancer" (1 trials), "Melanoma" (1 trials), "Metastatic Pancreatic Adenocarcinoma" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Urethelial Carcinoma" (1 trials). Many other conditions were trialed in "Norton Cancer Institute Research Program" in a lesser frequency.

Clinical Trials Intervention Types at Norton Cancer Institute Research Program


Most popular intervention types in "Norton Cancer Institute Research Program" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "CO-1.01" (1 trials), "Enoblituzumab" (1 trials), "MGA012" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Norton Cancer Institute Research Program


The vast majority of trials in "Norton Cancer Institute Research Program" are 2 trials for "All" genders.

Clinical Trials Status at Norton Cancer Institute Research Program


Currently, there are NaN active trials in "Norton Cancer Institute Research Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Norton Cancer Institute Research Program, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Norton Cancer Institute Research Program, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2